Disorders caused by impairments in the parathyroid hormone (PTH) signalling pathway are historically classified under the term pseudohypoparathyroidism (PHP), that encompasses rare, related but highly heterogeneous diseases with demonstrated (epi)genetic causes. The actual classification is based on the presence or absence of specific clinical and biochemical signs together with an in vivo response to exogenous PTH and the results of an in vitro assay to measure Gsa protein activity. However, this classification disregards other related diseases like acrodysostosis (ACRDYS) or Progressive Osseous Heteroplasia (POH), as well as recent findings of clinical and genetic/epigenetic background of the different subtypes. Therefore, the EuroPHP network decided to develop a new classification that encompasses all disorders with impairments in PTH and/or PTHrP cAMP-mediated pathway.

From Pseudohypoparathyroidism to inactivating PTH/PTHrP Signalling Disorder (iPPSD), a novel classification proposed by the European EuroPHP network

DE SANCTIS, Luisa;
2016-01-01

Abstract

Disorders caused by impairments in the parathyroid hormone (PTH) signalling pathway are historically classified under the term pseudohypoparathyroidism (PHP), that encompasses rare, related but highly heterogeneous diseases with demonstrated (epi)genetic causes. The actual classification is based on the presence or absence of specific clinical and biochemical signs together with an in vivo response to exogenous PTH and the results of an in vitro assay to measure Gsa protein activity. However, this classification disregards other related diseases like acrodysostosis (ACRDYS) or Progressive Osseous Heteroplasia (POH), as well as recent findings of clinical and genetic/epigenetic background of the different subtypes. Therefore, the EuroPHP network decided to develop a new classification that encompasses all disorders with impairments in PTH and/or PTHrP cAMP-mediated pathway.
2016
175
6
1
17
http://www.eje-online.org/content/175/6/P1.long
Thiele, Susanne; Mantovani, Giovanna; Barlier, Anne; Boldrin, Valentina; Bordogna, Paolo; DE SANCTIS, Luisa; Elli, Francesca; Freson, Kathleen; Garin, Intza; Grybek, Virginie; Hanna, Patrick; Izzi, Benedetta; Hiort, Olaf; Lecumberri, Beatriz; Pereda, Arrate; Saraff, Vrinda; Silve, Caroline; Turan, Serap; Usardi, Alessia; Werner, Ralf; Perez de Nanclares, Guiomar; Linglart, Agnès
File in questo prodotto:
File Dimensione Formato  
Eur J Endocrinol. 2016.pdf

Accesso aperto

Descrizione: Open access article
Tipo di file: PDF EDITORIALE
Dimensione 5.17 MB
Formato Adobe PDF
5.17 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1617501
Citazioni
  • ???jsp.display-item.citation.pmc??? 38
  • Scopus 107
  • ???jsp.display-item.citation.isi??? 91
social impact